AZYO
Price:
$1.49
Market Cap:
$24.21M
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, inc...[Read more]
Industry
Medical - Devices
IPO Date
2020-10-08
Stock Exchange
NASDAQ
Ticker
AZYO
According to Aziyo Biologics, Inc.’s latest financial reports and current stock price. The company's current ROE is 78.94%. This represents a change of 24.00% compared to the average of 63.66% of the last 4 quarters.
The mean historical ROE of Aziyo Biologics, Inc. over the last ten years is 82.70%. The current 78.94% ROE has changed -4.54% with respect to the historical average. Over the past ten years (40 quarters), AZYO's ROE was at its highest in in the June 2022 quarter at 686.49%. The ROE was at its lowest in in the March 2022 quarter at -124.24%.
Average
82.70%
Median
21.66%
Minimum
-183.66%
Maximum
653.63%
Discovering the peaks and valleys of Aziyo Biologics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.29%
Maximum Annual ROE = 653.63%
Minimum Annual Increase = -583.63%
Minimum Annual ROE = -183.66%
Year | ROE | Change |
---|---|---|
2022 | 653.63% | -455.90% |
2021 | -183.66% | 75.29% |
2020 | -104.77% | -583.63% |
2019 | 21.66% | -18.70% |
The current ROE of Aziyo Biologics, Inc. (AZYO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
121.73%
5-year avg
82.70%
10-year avg
82.70%
Aziyo Biologics, Inc.’s ROE is greater than Ainos, Inc. (-75.16%), greater than Surmodics, Inc. (-9.56%), greater than LENSAR, Inc. (-43.49%), greater than IRIDEX Corporation (-192.95%), greater than Establishment Labs Holdings Inc. (-184.55%), greater than CVRx, Inc. (-89.06%), greater than AxoGen, Inc. (-14.91%), less than Surgalign Holdings, Inc. (624.34%), greater than Artivion, Inc. (-0.29%), greater than Anika Therapeutics, Inc. (-48.10%), greater than Sight Sciences, Inc. (-47.28%), greater than Orthofix Medical Inc. (-21.25%), less than Avanos Medical, Inc. (1.28%), greater than Nexalin Technology, Inc. (-187.62%), greater than Ainos, Inc. (-75.16%), less than Electromed, Inc. (15.32%), less than Armm Inc. (0%), greater than STRATA Skin Sciences, Inc. (-91.63%), greater than INVO Bioscience, Inc. (-1073.76%), greater than enVVeno Medical Corporation (-48.73%),
Company | ROE | Market cap |
---|---|---|
-75.16% | $6.45M | |
-9.56% | $561.12M | |
-43.49% | $85.72M | |
-192.95% | $29.95M | |
-184.55% | $1.24B | |
-89.06% | $360.32M | |
-14.91% | $587.07M | |
624.34% | $0 | |
-0.29% | $1.19B | |
-48.10% | $248.54M | |
-47.28% | $203.53M | |
-21.25% | $722.63M | |
1.28% | $854.80M | |
-187.62% | $49.13M | |
-75.16% | $6.08M | |
15.32% | $251.96M | |
0% | $106.25K | |
-91.63% | $12.72M | |
-1073.76% | $3.25M | |
-48.73% | $59.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aziyo Biologics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aziyo Biologics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Aziyo Biologics, Inc.'s ROE?
How is the ROE calculated for Aziyo Biologics, Inc. (AZYO)?
What is the highest ROE for Aziyo Biologics, Inc. (AZYO)?
What is the 3-year average ROE for Aziyo Biologics, Inc. (AZYO)?
What is the 5-year average ROE for Aziyo Biologics, Inc. (AZYO)?
How does the current ROE for Aziyo Biologics, Inc. (AZYO) compare to its historical average?